Literature DB >> 9155692

Interstitial myofibroblasts: predictors of progression in membranous nephropathy.

I S Roberts1, C Burrows, J H Shanks, M Venning, L J McWilliam.   

Abstract

AIMS: To determine the role of interstitial myofibroblasts in the progression of membranous nephropathy; and to assess the predictive value of quantifying myofibroblasts in determining long term renal outcome.
METHODS: All cases of membranous nephropathy, diagnosed by renal biopsy at University Hospital of South Manchester between 1984 and 1987, were studied retrospectively. The biopsy specimens (n = 26) were reviewed and analysed morphometrically to measure interstitial volume as a proportion of the total volume of renal cortex, and numbers of interstitial myofibroblasts (cells positive for alpha-smooth muscle actin within the interstitium). Clinical data, with a follow up of seven to eight years, was available for 24 patients, and renal outcome was correlated with pathological changes in the initial diagnostic biopsy specimen.
RESULTS: The number of myofibroblasts and interstitial volume were inversely correlated with creatinine clearance at the initial biopsy, and at the end of follow up. Percentage sclerosed glomeruli or stage of glomerular disease, assessed by electron microscopy, did not correlate with renal function at initial biopsy or during follow up. The number of myofibroblasts, but not interstitial volume, correlated with severity of proteinuria at initial biopsy. Of 15 biopsy specimens showing no or mild interstitial fibrosis, four showed a notable increase in the number of interstitial myofibroblasts. All of these patients developed chronic renal failure, compared with three of 11 patients whose specimens showed no or a mild increase in myofibroblast numbers.
CONCLUSIONS: Interstitial myofibroblasts play a role in the development of interstitial fibrosis and progressive renal failure in membranous nephropathy. Increased numbers of myofibroblasts in biopsy specimens showing only mild fibrosis may predict subsequent chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155692      PMCID: PMC499736          DOI: 10.1136/jcp.50.2.123

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  27 in total

Review 1.  The biology of the myofibroblast.

Authors:  G Gabbiani
Journal:  Kidney Int       Date:  1992-03       Impact factor: 10.612

Review 2.  Loss of glomerular function and tubulointerstitial fibrosis: cause or effect?

Authors:  A C Ong; L G Fine
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

3.  Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data.

Authors:  H A Austin; D T Boumpas; E M Vaughan; J E Balow
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

4.  Myofibroblasts, predictors of progression of mesangial IgA nephropathy?

Authors:  D S Goumenos; C B Brown; J Shortland; A M el Nahas
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

Review 5.  The role of lymphocytes in the progression of interstitial disease.

Authors:  F Strutz; E G Neilson
Journal:  Kidney Int Suppl       Date:  1994-02       Impact factor: 10.545

6.  Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts.

Authors:  G Lonnemann; L Shapiro; G Engler-Blum; G A Müller; K M Koch; C A Dinarello
Journal:  Kidney Int       Date:  1995-03       Impact factor: 10.612

7.  Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury.

Authors:  C E Alpers; K L Hudkins; J Floege; R J Johnson
Journal:  J Am Soc Nephrol       Date:  1994-08       Impact factor: 10.121

Review 8.  Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions.

Authors:  A A Eddy
Journal:  J Am Soc Nephrol       Date:  1994-12       Impact factor: 10.121

Review 9.  Mechanisms of tubulo-interstitial injury in progressive renal diseases.

Authors:  L G Fine; A C Ong; J T Norman
Journal:  Eur J Clin Invest       Date:  1993-05       Impact factor: 4.686

10.  Interstitial myofibroblasts in IgA glomerulonephritis.

Authors:  T D Hewitson; G J Becker
Journal:  Am J Nephrol       Date:  1995       Impact factor: 3.754

View more
  32 in total

1.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

Authors:  J Yang; Y Liu
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

2.  Empagliflozin, SGLT2 inhibitor, attenuates renal fibrosis in rats exposed to unilateral ureteric obstruction: potential role of klotho expression.

Authors:  Noha A T Abbas; Amal El Salem; Mohammed M Awad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-08       Impact factor: 3.000

3.  Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis.

Authors:  Jun Yang; Song-Chang Lin; Gang Chen; Liqun He; Zhaoyong Hu; Lawrence Chan; JoAnn Trial; Mark L Entman; Yanlin Wang
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

4.  Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Authors:  Junwei Yang; Ryan W Shultz; Wendy M Mars; Rodney E Wegner; Yingjian Li; Chunsun Dai; Kari Nejak; Youhua Liu
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

5.  Role of myofibroblasts and collagen type IV in patients of IgA nephropathy as markers of renal dysfunction.

Authors:  R W Minz; A Bakshi; S Chhabra; K Joshi; V Sakhuja
Journal:  Indian J Nephrol       Date:  2010-01

6.  Expression of calponin in periglomerular myofibroblasts of rat kidney with experimental chronic injuries.

Authors:  So-Young Lee; Jae-Youn Choi; Dong-Chan Jin; Jin Kim; Jung-Ho Cha
Journal:  Anat Cell Biol       Date:  2010-06-30

7.  Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.

Authors:  Ivica Grgic; Eva Kiss; Brajesh P Kaistha; Christoph Busch; Michael Kloss; Julia Sautter; Anja Müller; Anuradha Kaistha; Claudia Schmidt; Girija Raman; Heike Wulff; Frank Strutz; Hermann-Josef Gröne; Ralf Köhler; Joachim Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-13       Impact factor: 11.205

8.  Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.

Authors:  Junwei Yang; Chunsun Dai; Youhua Liu
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  The expression of cytoskeletal proteins (alpha-SMA, vimentin, desmin) in kidney tissue: a comparison of fetal, normal kidneys, and glomerulonephritis.

Authors:  G Gonlusen; M Ergin; S Paydaş; N Tunali
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

10.  Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling.

Authors:  Kebin Hu; Chuanyue Wu; Wendy M Mars; Youhua Liu
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.